However, failure to silence DUX4 in FSHD leads to aberrant expression in skeletal muscle cells and initiates a cascade of events that ultimately lead to pathology [4, 7, 11, 12]. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.